Organization: Health Canada
Year: 2024
Month: February
Request Number: A-2023-000426
Request Summary: PERIODIC SAFETY UPDATE REPORT #3 for COVID-19 VACCINE (nucleoside modified) (BNT162b2) to the European Medical Agency (EMA) on Aug 18, 2022 which covered the period from December 19, 2021 through June 18, 2022. Health Canada's and the Public Health Agency of Canada's research findings, reviews & results of the above-captioned document including any internal or external communications.
Disposition: Disclosed in part
Number of pages: 278